Repurposing the yellow fever vaccine for intratumoral immunotherapy-Reference-Cited by-同舟云学术

Repurposing the yellow fever vaccine for intratumoral immunotherapy

Published:2019-11-19 Issue:1 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Aznar Maria Angela¹^ORCID,Molina Carmen¹,Teijeira Alvaro¹²³,Rodriguez Inmaculada¹²³,Azpilikueta Arantza¹³,Garasa Saray¹³,Sanchez‐Paulete Alfonso R¹,Cordeiro Luna¹³,Etxeberria Iñaki¹,Alvarez Maite¹,Rius‐Rocabert Sergio⁴⁵,Nistal‐Villan Estanislao⁴⁵,Berraondo Pedro¹²³,Melero Ignacio¹²³^ORCID

Affiliation:

1. Center for Applied Medical Research (CIMA) University of Navarra Pamplona Spain

2. CIBERONC Madrid Spain

3. Instituto de investigación de Navarra (IDISNA) Pamplona Spain

4. Microbiology Section Dpto. CC, Farmaceuticas y de la Salud Facultad de Farmacia Universidad CEU San Pablo CEU University Boadilla del Monte, Madrid Spain

5. Instituto de Medicina Molecular Aplicada (IMMA) Universidad CEU San Pablo, Pablo‐CEU, CEU Universities Boadilla del Monte, Madrid Spain

Funder

Ministerio de Economía y Competitividad

Fundación Científica Asociación Española Contra el Cáncer

Cancer Research Institute

Fundación BBVA

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201910375

Reference62 articles.

1. Role of PD-1 during effector CD8 T cell differentiation

2. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

3. Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

4. Consensus nomenclature for CD8+T cell phenotypes in cancer

5. Programmed Cell Death 1-Directed Immunotherapy for Enhancing T-Cell Function

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing for cancer therapy;Signal Transduction and Targeted Therapy;2024-04-19

2. YF17D‐based vaccines – standing on the shoulders of a giant;European Journal of Immunology;2024-04-03

3. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms;Frontiers in Immunology;2024-02-15

4. Molecular insights and promise of oncolytic virus based immunotherapy;Advances in Protein Chemistry and Structural Biology;2024

5. Investigation of oncolytic potential of vaccine strains of yellow fever and tick-borne encephalitis viruses against glioblastoma and pancreatic carcinoma cell lines;Problems of Virology;2023-12-26